newsfilter
← Latest News
GlobeNewswire·

Editas Medicine to Announce First Quarter 2025 Financial Results and to Participate in Investor Conference in May

CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that it